|
Big Savings With More Pharmacist Prescribing Authority
|
|
Expanding pharmacists’ authority to prescribe medications for minor illnesses could save millions of dollars in U.S. healthcare costs, according to a new study. It would also mean quicker and easier access to care, with the conditions resolving in nearly all cases. Find out why the researchers say it is so important to consider the change.
|
|
|
Semaglutide Shown to Reduce Cardiovascular, Kidney Events
|
|
|
Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Semaglutide has reduced the risk by 24% for a composite of kidney outcomes and death due to cardiovascular and kidney causes compared with those who received placebo, according to a report published in the New England Journal of Medicine. Read more.
|
|
What Is the Age Limit for Safe Use of Statins?
|
|
|
When pharmacists are looking at chronic disease medications to discontinue in patients of advancing age, statins should probably not be on the list, according to a new study. Find out why University of Hong Kong researchers concluded that a reduction in cardiovascular events after statin therapy was seen in patients aged 75 years or older without increasing risks for severe adverse effects.
|
|
|
Chlorthalidone Found to Be Better for Hypertensive Patients
|
|
When deciding whether older patients should receive chlorthalidone or hydrochlorothiazide for hypertension, prior myocardial infarction or stroke should be taken into account, according to the authors of a new study in the Journal of the American Medical Association Network Open. The authors found that patients on chlorthalidone appeared to have a lower risk of major adverse cardiovascular events and other noncancer deaths. Read more.
|
|
